and weight concerns in women. She is presently involved in randomized trials that are testing whether modifications in diet and level of physical activity can alter biological processes and progression of cancer. She currently serves on editorial boards for several peer-reviewed journals and has been an invited participant in several NIH review committees, workshops, and meetings.
Jerrold M. Ward, D.V.M., Ph.D., recently became chief, Infectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, under a contract to So Bran, Inc.; most recently he was chief of the Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute (NCI), Frederick, Maryland, during the period of report preparation. He was also formerly head, Tumor Pathology, National Toxicology Program (NTP), NCI, Bethesda. Dr. Ward is an expert in the field of veterinary and toxicologic pathology. He was involved with the early development of the NCI bioassay program, publication of the first 200 NCI and NTP carcinogenesis bioassay reports (blue books), and was later a member of the NTP Technical Reports Subcommittee of the NTP Board of Scientific Councilors. Dr. Ward received his D.V.M. from Cornell University and his Ph.D. in comparative pathology from the University of California, Davis, and is board-certified in veterinary pathology (Diplomate, ACVP). He has served on several editorial boards of pathology journals and as an advisor for safety evaluation of toxins, carcinogenesis, and pathology in several capacities. Dr. Ward has also contributed to writing the Society for Toxicologic Pathology Guidelines for Toxicologic Pathology and has over 350 publications. He is the recipient of the NIH Director’s Award for the discovery of a new Helicobacter and the FDA Commissioner’s Special Citation for contribution to the Interagency Working Group on Nitrite Research.